FARALLON CAPITAL MANAGEMENT, L.L.C.FARALLON CAPITAL MANAGEMENT, L.L.C.

Institutional investor · Portfolio as of Q3 2024

Top Holdings165 positions

Checking export access…
Activity:
SPYSPY
PUT

STATE STR SPDR S&P 500 ETF T

5.3M$3B13.4%———
Decreased
—

HESS CORP

6.4M$875.2M3.8%——
4 qtrssince 2023-Q4
Decreased
0
RSPRSP
PUT

INVESCO EXCHANGE TRADED FD T

4.4M$788.3M3.5%———
New
—

IQVIA HLDGS INC

3.2M$751.5M3.3%$170.94+37.35%
24 qtrssince 2018-Q4
Increased
63

EXELIXIS INC

25.4M$659.4M2.9%$19.40+33.73%
24 qtrssince 2018-Q4
Decreased
0

UNITEDHEALTH GROUP INC

1.1M$641.9M2.8%$451.86+23.36%
7 qtrssince 2023-Q1
Decreased
0

MICROSOFT CORP

1.5M$631.1M2.8%$251.27+68.59%
24 qtrssince 2018-Q4
Increased
65

AON PLC

1.7M$590.3M2.6%$303.01+12.99%
3 qtrssince 2024-Q1
Decreased
0

NATERA INC

4.6M$578.6M2.5%$67.01+89.46%
14 qtrssince 2021-Q2
Increased
55

TRANSUNION

5.5M$573.3M2.5%$86.03+20.02%
24 qtrssince 2018-Q4
Decreased
0

DISNEY WALT CO

5.8M$560.7M2.5%$95.59-1.66%
2 qtrssince 2024-Q2
Increased
78

SALESFORCE INC

2M$559.7M2.5%$200.22+34.74%
20 qtrssince 2019-Q4
Decreased
0

REVOLUTION MEDICINES INC

11.3M$513.3M2.3%$33.17+33.17%
15 qtrssince 2021-Q1
Increased
62
CTLTCTLTDelisted

CATALENT INC

8.4M$508.4M2.2%——
4 qtrssince 2023-Q4
Increased
59

NEW YORK TIMES CO MTN BE

8.7M$486.8M2.1%$41.34+31.49%
18 qtrssince 2020-Q2
Decreased
0

BOSTON SCIENTIFIC CORP

5.4M$454.7M2.0%$51.57+62.49%
17 qtrssince 2020-Q3
Increased
63

ARAMARK

11.6M$450.7M2.0%$25.80+47.25%
16 qtrssince 2020-Q4
Decreased
0

THERMO FISHER SCIENTIFIC INC

709,456$438.8M1.9%$431.27+42.43%
20 qtrssince 2019-Q4
Decreased
0

ALPHABET INC

2.4M$403M1.8%$114.18+45.41%
24 qtrssince 2018-Q4
Increased
63

WABTEC

2.2M$402M1.8%$83.24+116.31%
24 qtrssince 2018-Q4
Increased
49
$22.8B
AUM
165
Positions
Q3 2024
Filing
HI score · 1.0/5
Quarterly 13F Value Change
+9%Q2'23$19.9B+8%Q3'23$21.4B+2%Q4'23$21.9B+8%Q1'24$23.6B-1%Q2'24$23.3B-2%Q3'24$22.8B
Activity profile
$ moved · Q3'24
New19%Increased26%Decreased50%Exited6%
Composition
Equity vs derivatives
Equity80%Puts20%Calls0%
Holding period
Avg 2.2 years
<1Q11%1-4Q29%1-2Y14%2Y+46%

FARALLON CAPITAL MANAGEMENT, L.L.C. manages $22.8B across 165 positions as of Q3 2024. Top holdings: SPY puts (13.4%), HES (3.8%), RSP puts (3.5%). Fund DNA: Balanced Allocator. HoldingsIntel Score: 1/5.0.

Q3 2024 Summary

Active quarter - 22 new positions, 24 exits, 42 increased. Top move: DIS (INCREASED, conviction 78). Portfolio: $22.8B across 165 positions.

Top holdings by portfolio weight

Total AUM$18B
HES3.84%
IQV3.30%
EXEL2.89%
UNH2.82%
MSFT2.77%
AON2.59%
NTRA2.54%
TRU2.51%
DIS2.46%
CRM2.46%
Other2.25%

Portfolio allocation by GICS sector

Sectors11
Healthcare35.81%
Unknown16.86%
Technology13.51%
Financial Services11.87%
Communication Services8.32%
Industrials6.71%
Real Estate2.84%
Consumer Cyclical1.74%
Basic Materials1.18%
Consumer Defensive1.16%
Other0.01%

Behavioral investing profile

Checking access…
Balanced Allocator- primarily Healthcare, Unknown, Technology
Compare DNA across all funds
7-dimension, SEC 13F-derived research score
Weak(1.0 / 5.0)
Holdings P&L46
Conviction44
Concentration66
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

Security
7Q
BBIOBBIOBRIDGEBIO PHARMA INC
Q4 2024 → Q2 2026+9M shares+$755.7M
7Q
CRNXCRNXCRINETICS PHARMACEUTICALS IN
Q4 2024 → Q2 2026+7.8M shares+$277M
5Q
BSXBSXBOSTON SCIENTIFIC CORP
Q2 2025 → Q2 2026+6.8M shares+$69.5M
Checking access…

Famous Investors' Portfolios

What the most-followed managers hold, and what they bought and sold each quarter.

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Verify source filings on SEC EDGAR

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used